M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Barriers to Initiation of Antiretroviral Treatment in Rural and Urban Areas of Zambia: A Cross-Sectional Study of Cost, Stigma, and Perceptions about ART
TL;DR: Patients in home-based care for HIV/AIDS who never initiated ART perceived greater financial and logistical barriers to seeking HIV care and had more negative perceptions about the benefits of the treatment.
Journal ArticleDOI
Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment
Alana T. Brennan,Lawrence Long,Mhairi Maskew,Ian Sanne,Imogen Jaffray,Patrick MacPhail,Matthew P. Fox +6 more
TL;DR: The utilization of nurse-managed PHCs for treatment maintenance of stable patients could decrease the burden on specialized doctor-managed ART clinics and patient outcomes for down-referred patients at PHCs appear equal, if not better, than those achieved at ART clinics.
Journal ArticleDOI
Early effects of antiretroviral therapy on work performance: Preliminary results from a cohort study of Kenyan agricultural workers.
Bruce A. Larson,Matthew P. Fox,Sydney Rosen,Margaret Bii,Carolyne Sigei,Douglas Shaffer,Fredrick Sawe,Monique Wasunna,Jonathon L Simon +8 more
TL;DR: Treatment had a large, positive impact on the ability of workers to undertake their primary work activity, harvesting tea, in the first year on ART, according to conservatively estimate that workers worked at least twice as many days in the month than they would have in the absence of ART.
Journal ArticleDOI
Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
Andreas D Haas,Elizabeth Zaniewski,Nanina Anderegg,Nathan Ford,Matthew P. Fox,Michael J. Vinikoor,François Dabis,Denis Nash,Jean d’Amour Sinayobye,Théodore Niyongabo,Aristophane Tanon,Armel Poda,Adebola Adedimeji,Andrew Edmonds,Mary-Ann Davies,Matthias Egger,Matthias Egger +16 more
TL;DR: This work describes retention on ART in sub‐Saharan Africa, first based on observed data as recorded in the clinic databases, and second adjusted for undocumented deaths and self‐transfers.
Journal ArticleDOI
Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/μl is associated with improved treatment outcomes in South Africa
Matthew P. Fox,Matthew P. Fox,Ian Sanne,Francesca Conradie,Jennifer Zeinecker,Catherine Orrell,Prudence Ive,Mohammed Rassool,Marjorie Dehlinger,Charles van der Horst,James McIntyre,Robin Wood +11 more
TL;DR: Patients initiating ART with higher CD4 cell counts had reduced mortality, tuberculosis and less virologic failure than those initiated at lower CD4 cells/μl, and the data support increasingCD4 cell count eligibility criteria for ART initiation.